Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 5/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.57 |
| ▸ | HPGD | P15428 | 5/20 | 0.57 |
| ▸ | MAPT | P10636 | 4/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.57 |
| ▸ | MAOA | P21397 | 4/20 | 0.51 |
| ▸ | MAOB | P27338 | 3/20 | 0.51 |
| ▸ | NPC1 | O15118 | 4/20 | 0.48 |
| ▸ | RAB9A | P51151 | 4/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | TNKS | O95271 | 1/20 | 0.47 |
| ▸ | PARP1 | P09874 | 1/20 | 0.47 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.47 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30743074 | 1.00 | AHR (0.59) | AHRMEN1KMT2AHPGDMAPT | |
| SCHEMBL16809358 | 0.96 | AHR (0.55) | AHRMEN1KMT2AHPGDMAPT | |
| SCHEMBL883673 | 0.94 | MAOA (0.60) | AHRMEN1KMT2AHPGDMAPT | |
| SCHEMBL13564024 | 0.90 | DYRK1A (0.49) | AHRMEN1KMT2AHPGDMAPT | |
| SCHEMBL17899746 | 0.89 | AHR (0.52) | AHRMEN1KMT2AHPGDMAPT | |
| SCHEMBL9927267 | 0.89 | MAOB (0.53) | AHRMEN1KMT2AHPGDMAPT | |
| SCHEMBL2628169 | 0.88 | MAOA (0.67) | MEN1KMT2AHPGDMAPTALDH1A1 | |
| SCHEMBL4983500 | 0.88 | MAOB (0.54) | AHRMEN1KMT2AHPGDMAPT | |
| SCHEMBL15785771 | 0.88 | MAPT (0.55) | AHRMEN1KMT2AHPGDMAPT | |
| SCHEMBL18685586 | 0.88 | SMN1; SMN2 (0.52) | AHRMEN1KMT2AHPGDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1590 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12048242-B2 | Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2024-07-23 | — | — | US | disclosed |
| US-12048238-B2 | Organometallic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-07-23 | — | — | US | disclosed |
| US-20240239754-A1 | PHENANTHROIMIDAZOLE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | GUANGDONG UNIVERSITY OF TECHNOLOGY (CN) | 2024-07-18 | — | — | US | disclosed |
| US-20240239754-A1 | PHENANTHROIMIDAZOLE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | GUANGDONG UNIVERSITY OF TECHNOLOGY (CN) | 2024-07-18 | — | — | US | disclosed |
| US-20240239824-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-07-18 | — | — | US | disclosed |
| US-20240244950-A1 | ORGANIC LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-07-18 | — | — | US | disclosed |
| US-20240244856-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, ELECTRONIC APPARATUS, AND PRODUCTION METHOD FOR ORGANIC ELECTROLUMINESCENCE ELEMENT | IDEMITSU KOSAN CO.,LTD. (JP) | 2024-07-18 | — | — | US | disclosed |
| US-20240244858-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-07-18 | — | — | US | disclosed |
| US-20240244870-A1 | LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-07-18 | — | — | US | disclosed |
| US-20240244860-A1 | LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-07-18 | — | — | US | disclosed |
| US-20080009527-A1 | INHIBITION OF RAF KINASE USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS | BAYER HEALTHCARE LLC | 2008-01-10 | — | — | US | disclosed |
| EP-1854798-A2 | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function | Bristol-Myers Squibb Company (US) | 2007-11-14 | — | — | EP | disclosed |
| US-20070244120-A1 | INHIBITION OF RAF KINASE USING SUBSTITUTED HETEROCYCLIC UREAS | BAYER HEALTHCARE LLC | 2007-10-18 | — | — | US | disclosed |
| EP-1319007-B9 | FUSED HETEROCYCLIC SUCCINIMIDE COMPOUNDS AND ANALOGS THEREOF, MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION | BRISTOL MYERS SQUIBB CO (US) | 2007-10-10 | — | — | EP | disclosed |
| US-7255998-B1 | High sensitivity immunoassay method | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2007-08-14 | — | — | US | disclosed |
| US-7255998-B1 | High sensitivity immunoassay method | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2007-08-14 | — | — | US | disclosed |
| US-7196089-B2 | EP4 receptor antagonists | ASTERAND UK LIMITED (GB) | 2007-03-27 | — | — | US | disclosed |
| US-7179815-B2 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | NEUROCRINE BIOSCIENCES, INC. (US) | 2007-02-20 | — | — | US | disclosed |
| US-20070010559-A1 | Indole derivatives for use as chemical uncoupler | NOVO NORDISK A/S (DK) | 2007-01-11 | — | — | US | disclosed |
| US-20070004794-A1 | Novel salicylic anilides | NOVO NORDISK A/S (DK) | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239754-A1 | PHENANTHROIMIDAZOLE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | PAH, HTR3D, CYP3A4 | AHR 70/4885MEN1 3312/4885KMT2A 1185/4885 |
| US-12048238-B2 | Organometallic compound and organic light-emitting device including the same | TRPC1, PPOX, LAGE3 | AHR 3274/4885MEN1 183/4885KMT2A 882/4885 |
| US-20240244950-A1 | ORGANIC LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME | EML4, DNMT3L, LIN28A | AHR 2869/4885MEN1 1543/4885KMT2A 936/4885 |
| US-20070244120-A1 | INHIBITION OF RAF KINASE USING SUBSTITUTED HETEROCYCLIC UREAS | BRAF, RAF1, ARAF | AHR 2489/4885MEN1 2248/4885KMT2A 1462/4885 |
| US-12048242-B2 | Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device | RER1, LEF1, MLX | AHR 4438/4885MEN1 654/4885KMT2A 1826/4885 |
| US-20070004794-A1 | Novel salicylic anilides | FABP4, ADIPOR1, ADIPOR2 | AHR 906/4885MEN1 4710/4885KMT2A 3568/4885 |
| US-20240244858-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | CRY1, CRY2, C1S | AHR 1171/4885MEN1 357/4885KMT2A 3002/4885 |
| US-20240239824-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | C1S, CHRM1, L1CAM | AHR 1009/4885MEN1 115/4885KMT2A 3829/4885 |
| US-20080009527-A1 | INHIBITION OF RAF KINASE USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS | BRAF, RAF1, ARAF | AHR 806/4885MEN1 2970/4885KMT2A 1256/4885 |
| US-20070010559-A1 | Indole derivatives for use as chemical uncoupler | GPR119, IDO2, IDO1 | AHR 15/4885MEN1 4192/4885KMT2A 1438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.